Rebiotix Inc., a Ferring Company

Rebiotix Inc., a Ferring Company, is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating diseases by harnessing the power of the human microbiome. The company is on the forefront of an exciting potential medical breakthrough with our MRT drug platform. The MRT drug platform is leveraged to develop formulations consisting of live microbes, which are evaluated through our clinical program for the formulation’s ability to address challenging diseases. We have the most advanced human clinical program with extensive clinical trial experience in multiple indications, evaluating an investigative microbiota-based live biotherapeutic drug.